MYRF and myeloid sarcoma: Furthermore, the same study reported that fewer Sox10+/NogoA+ cells were Myrf+ in chronic MS lesion centers than in shadow plaques, indicating that a lack of Myrf may contribute to remyelination failure in some MS lesions.